Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin

Summary

The purpose of this study is to investigate the efficacy and safety of Cycloset® and placebo when added to metformin monotherapy (at least 1000 mg/day for 3 months prior to screening) in persons with type 2 diabetes mellitus who are not adequately controlled on metformin therapy alone.

Timeline

Start

2005-02

Primary completion

2006-02

Completion

2006-03

Drugs

Indications